Mirae Asset Global Investments Co., Ltd. Emergent Bio Solutions Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$1.5 - $3.41 $33,583 - $76,346	22,389 New	22,389 $56,000
Q3 2023 Oct 26, 2023	SELL	$3.17 - $7.91 $63,063 - $157,361	-19,894 Reduced 47.05%	22,389 $76,000
Q2 2023 Aug 10, 2023	BUY	$7.35 - $13.21 $40,285 - $72,404	5,481 Added 14.89%	42,283 $310,000
Q1 2023 May 04, 2023	BUY	$7.79 - $16.29 $100,857 - $210,906	12,947 Added 54.27%	36,802 $381,000
Q4 2022 Feb 09, 2023	BUY	$11.0 - $21.45 $13,145 - $25,632	1,195 Added 5.27%	23,855 $281,000
Q3 2022 Nov 10, 2022	BUY	$20.09 - $35.8 $141,272 - $251,745	7,032 Added 45.0%	22,660 $476,000
Q2 2022 Jul 26, 2022	BUY	$27.42 - $43.63 $428,519 - $681,849	15,628 New	15,628 $485,000

172

36.8M

336K

203K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.